An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...

Women whose breast cancers need estrogen to grow are often treated for five or more years with medications to lower estrogen production or block its effects. Broadly known as endocrine therapy, the ...

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

Real-world data highlight gaps in genetic testing and targeted therapy use for metastatic castration-resistant prostate ...

Responses were similar among patients with estrogen patches and ARPIs compared to luteinizing hormone releasing hormone ...

Captain Wild Bill Wichrowski has been open with Deadliest Catch fans about his cancer battle. Here's the latest update.

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

Nubeqa plus ADT improved rPFS in mHSPC regardless of disease volume, reducing the risk of radiological progression or death ...

Chhavi Mittal, who was diagnosed with early-stage breast cancer in 2022, took a toll on the criticism she received for her ...

Patients with mHSPC benefited from darolutamide + ADT + docetaxel irrespective of age (<75 years and ≥75 years), with consistent improvements in overall survival, time to mCRPC, and time to initiation ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

It is a useful therapy with several drawbacks that limit its effectiveness, including prolonged light sensitivity, poor ...